Platelet-rich plasma in the treatment of knee osteoarthritis: a randomized, double-blinded, controlled trial

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000034786

Enrollment

Unknown

Registered

2020-07-19

Start date

2019-01-01

Completion date

Unknown

Last updated

2020-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Interventions

Experimental group:platelet-rich plasma (PRP)

Control group:hyaluronic acid

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients with knee osteoarthritis

Exclusion criteria

Exclusion criteria: 1. Patients aged less than 18 years; 2. History of knee operations; 3. History of knee intra-articular injections or oral NASID in the past 6 months; 4. Unable to receive pre-treatment assessment and post-treatment follow-up; 5. Patients with blood diseases.

Design outcomes

Primary

Measure	Time frame
VAS scores;	—

Countries

China

Contacts

Public ContactHe Hongchen

West China Hospital, Sichuan University

h0794062@scu.edu.cn+86 15680670929

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026